Company intelligence
Cantourage
Enabling a fully functioning cannabis eco-system in Europe
About Cantourage
Cantourage is a leading European medical cannabis provider. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffman. Cantourage empowers producers from around the globe to introduce their products to the growing and profitable European market faster and more cost-effectively – while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, dronabinol and pharmaceutical-grade cannabidiol.
Verified activity
Signals from Cantourage
2 published signals
Presence & Recognition
Cantourage CEO Philip Schetter presented the company at the EF Equity Forum Herbstkonferenz in Frankfurt.
Reported by Cantourage
Capital & Finance
Cantourage expects consolidated revenue in a range of EUR 85 million to EUR 95 million and consolidated adjusted EBITDA in a range of EUR 10 million to EUR 12 million for the 2026 financial year based on business performance to date and expectations for the remainder of the year.
Reported by Cantourage